Industry News 23 Oct 2026

Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01

Source: Finanznachrichten.de •1 min read

EVX-01 induced an immune response in all patients in the trial with 89% of the vaccine neoantigens generating potent specific T-cell responses Three-year data from the EVX-01 phase 2 trial in patie...

This is a short summary. The full story is published by Finanznachrichten.de.

Read full story at Finanznachrichten.de
#announces#cell#clinical#evaxion#phase 2#precision#responses#target#three#trial#vaccine#year

Related news

Industry News
Palleon Pharmaceuticals Presents Phase 2 Results for HLX79/E-602 in Primary Membranous Nephropathy at ASN Kidney Week…

Palleon Pharmaceuticals, a clinical-stage biotechnology company developing glycan editing therapeutics for autoimmune disease and cancer, today…

Financialcontent• 23 Oct 2026 •1 min read
#pharmaceutical#pharmaceuticals#phase 2
Read story
Regulatory
AMA and EMA issue joint guidance on Ebola vaccine development

EMA’s Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely start of…

EMA• 23 Oct 2026 •1 min read
#clinical trial#vaccine
Read story
Industry News
FDA Approval Of First Potential Hep B Cure Comes Amid Heated Vaccine Debate

Body: FDA’s approval this week of the first functional cure for hepatitis B was celebrated by the Hepatitis B Foundation as a significant step…

Insidehealthpolicy• 22 Oct 2026 •1 min read
#diseases#fda approval#vaccine
Read story
Industry News
S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility

Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer…

Medical News• 20 Oct 2026 •1 min read
#cell#clinical trial#gmp
Read story
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Trending tags
#pharma #pharmaceutical #fda approval #diseases #pharmaceuticals #clinical trial #fda approves #pharma and healthcare #biosimilar #phase iii #science and innovations #research #vaccine #drug #world news
Browse by category
Industry News 89 Regulatory 5
Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit